Codon Devices Settles Patent Suit

Synthetic biology startup Codon Devices of Cambridge, MA, announced today that it has reached a settlement with Blue Heron Biotechnology of Bothell, WA, in a patent suit that Codon filed against the Washington firm last March. The suit involved five patents that were exclusively licensed to Codon—one from MIT and four from Duke University. As part of the agreement, financial terms of which were not disclosed, Codon has granted Blue Heron a sublicense on the technology.

Rebecca is Xconomy's co-founder. Follow @

Trending on Xconomy